VOYA Investment Management
RLMD icon

VOYA Investment Management’s Relmada Therapeutics RLMD Stock Holding History

VOYA Investment Management’s Portfolio RLMD Stock Details RLMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$124K Buy
+17,940
New +$125K ﹤0.01% 2329
2023
Q2 		– Sell
-10,752
Closed -$24.3K – 2984
2023
Q1 		$24.3K Hold
10,752
– – ﹤0.01% 2863
2022
Q4 		$37.5K Sell
10,752
-9,585
-47% -$84.2K ﹤0.01% 2880
2022
Q3 		$753K Buy
20,337
+10,045
+98% +$278K ﹤0.01% 1785
2022
Q2 		$195K Buy
+10,292
New +$224K ﹤0.01% 2407
2021
Q2 		– Sell
-7,064
Closed -$249K – 2883
2021
Q1 		$249K Buy
+7,064
New +$247K ﹤0.01% 2415
2020
Q3 		– Sell
-4,885
Closed -$219K – 2520
2020
Q2 		$219K Buy
+4,885
New +$207K ﹤0.01% 2109

Other funds holding RLMD

JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $322M AUM
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JHC
Jones Hill Capital New York $470M AUM
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

VOYA Investment Management's RLMD Position: Q2 2026 in Review

VOYA Investment Management opened a new position in Relmada Therapeutics (RLMD) in Q2 2026: 17,940 shares worth $124K. The stake represents ﹤0.01% of the portfolio and ranks #2329 among its holdings. This is a return to the name: VOYA Investment Management previously reported a position in RLMD as recently as Q1 2023.

VOYA Investment Management first reported a position in RLMD in Q2 2020 and has held it in 7 quarters since. The position peaked at $753K in Q3 2022. 126 funds tracked by Wall St. Rank hold RLMD as of Q2 2026.

  • VOYA Investment Management held 17,940 shares of Relmada Therapeutics worth $124K as of Q2 2026.
  • Relmada Therapeutics was a new VOYA Investment Management position in Q2 2026.
  • Relmada Therapeutics made up ﹤0.01% of VOYA Investment Management's portfolio in Q2 2026, its #2329 holding.
  • VOYA Investment Management first reported a position in Relmada Therapeutics in Q2 2020 and has held it in 7 quarters since.
  • VOYA Investment Management's Relmada Therapeutics position peaked at $753K in Q3 2022.
  • 126 funds tracked by Wall St. Rank held Relmada Therapeutics as of Q2 2026.

Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.